Research utilizing a systems approach demonstrates that different vaccines lead to immunity via distinct immune response pathways. Published findings include interactive figures linked to the underlying data allowing readers seamless access to...
4/16/2013 4:30 PM EDT
International researchers led by Chris Amemiya, PhD, Benaroya Research Institute at Virginia Mason, has published “The African coelacanth genome provides insights into tetrapod evolution” as the cover article in the April 18 issue of Nature.
4/16/2013 12:55 PM EDT
Benaroya Research Institute establishes the T1D Exchange Biobank Operations Center to advance discoveries in type 1 diabetes research with biosamples from thousands of participants.
2/14/2013 9:00 AM EST
Findings offer a better understanding of the development and progression of multiple sclerosis and potential future therapeutic target.
1/30/2013 2:00 PM EST
On Nov. 14th, World Diabetes Day, 12 Puget Sound area diabetes organizations and landmarks will identify Seattle as a global leader in diabetes research and clinical care by joining the “Blue Monument Challenge.”
11/7/2012 8:00 AM EST
BRI announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Brad Stone, PhD, Principal Investigator for the grant, will pursue a research project entitled "Rapid Vaccine...
11/1/2012 1:00 PM EDT
In a new $4.3 million grant from the NIH, scientists from Benaroya Research Institute at Virginia Mason, Seattle Children’s Research Institute and University of Virginia combine their expertise in three different areas of research in order to...
10/18/2012 4:35 PM EDT
Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases, including Type 1 diabetes,...
9/11/2012 6:00 AM EDT